Daniel Bloodgood

Scientist II, Experimental Science at Dyno Therapeutics

Dan received his PhD in Neuroscience from UNC-Chapel Hill. In his dissertation work he used a variety of viral genetic approaches to perform anatomical tract tracing and probe brain circuit dysfunction in psychiatric disorders. Prior to joining Dyno, he did a postdoctoral fellowship at Stanford University where he used AAV-based gene delivery to reduce protein aggregation in a model of Parkinson’s Disease. He particularly enjoys using automated approaches to analyze large microscopy data sets.

Location

Cambridge, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Dyno Therapeutics

4 followers

Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.


Employees

51-200

Links